Substance / Medication

Sucroferric oxyhydroxide

Overview

Active Ingredient
sucroferric oxyhydroxide
RxNorm CUI
1484283

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

2 trials linked to this intervention

2
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate: A systematic review and meta-analysis.
Georgopoulos Christos, Duni Anila, Stamellou Eleni et al. · Hemodial Int · 2025
PMID: 39422162Meta-AnalysisFull text (PMC)
Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease.
Greenbaum Larry A, Jeck Nikola, Klaus Günter et al. · Pediatr Nephrol · 2021
PMID: 33106892ObservationalFull text (PMC)
Chronic Therapy with Sucroferric Oxyhydroxide Does Not Affect Iron and Anemia Markers in Dialysis Patients.
Lioulios Georgios, Stangou Maria, Sarafidis Pantelis A et al. · Blood Purif · 2020
PMID: 32050202Observational
[Short-term effects with sucroferric oxyhydroxide in hemodialysis patients: Experience in NephroCare France].
Chazot Charles, Fadel Baya, Kareche Mimi et al. · Nephrol Ther · 2019
PMID: 30639044Observational
[Low Continuity Rate of Sucroferric Oxyhydroxide among Japanese Hemodialysis Patients with High Phosphate Binder Pill Burden].
Mitsuboshi Satoru, Yamada Hitoshi, Nagai Kazuhiko et al. · Yakugaku Zasshi · 2018
PMID: 29311459Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sucroferric oxyhydroxide (substance)
SNOMED CT
737661000168109
UMLS CUI
C3696416
RxNorm CUI
1484283

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.